spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

CIDP Showcases Full Suite of Services at in-cosmetics North America 2017

CIDP (Centre International de Développement Pharmaceutique)

Independent CRO Adds Ex Vivo Model to its Claims Substantiation Protocols

Mauritius, 29 September 2017 – CIDP, Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organisation (CRO), will bring its full suite of services – comprising research activities, in vitro and ex vivo testing, analytical chemistry, formulation, and clinical research – to in-cosmetics North America 2017. CIDP will also present its innovative anti-pollution and blue light study protocols, and reveal a new ex vivo model at the show.

Earlier this year, CIDP unveiled its innovative study protocol for substantiating anti-pollution claims on cosmetic products. Since then, the company has developed an ex vivo model as an addition to its anti-pollution and blue light claim substantiation protocols. This new model allows experiments to be conducted in conditions close to the in vivo model.

The ex vivo model of viable full-thickness skin explants reproduces the same mechanisms that are activated in the different cell layers of the human skin, enabling CIDP researchers to closely monitor the effects of pollution on the skin.

On 11 October at 11:10am, Mrs Véronique NEWTON, Preclinical Laboratory Manager at CIDP, will present the company’s standard protocols for objective substantiation of anti-pollution claims. She will also share more about CIDP’s successful creation of an ex vivo model that mimics in vivo conditions.

“CIDP aims to be the ideal partner to cosmetic manufacturers for their research needs,” commented Mr Jean-Louis ROULE, CEO of CIDP. “Our anti-pollution and blue light protocols had been well-received in Europe, and we’re excited to introduce our ex vivo protocol at in-cosmetics North America this year. The United States is an important market for CIDP, and we’re looking to build on our success in Europe, and strengthen our international strategy by establishing our presence here.”

Visitors can learn more about CIDP’s study protocols and full suite of services at Stand B1.

For more information, please visit www.cidp-cro.com.



phone +230 401 2600
email info@cidp-cro.com
web www.cidp-cro.com/
email BioPark Mauritius, Socota Phoenicia, Sayed Hossen Road, Phoenix 73408, Mauritius
 
Print this page
Send to a friend
   
spacer
News and Press Releases

Fifth Annual Peptides Congress: Registration Now Open

Join us at the forefront of industry innovation at the 5th Annual Peptides Congress, 16-17 April 2018 in London to shape the future of industry discussion. With over 700 peptides in clinical trials and an increasing industry focus on biologics, now more than ever is the time to focus on this revolutionary field!
More info >>


White Papers

Exploring Protein Stability by nanoDSF

NanoTemper Technologies GmbH

nanoDSF determines thermal and chemical protein stability with ultra-high resolution and with unmatched reproducibility. The detection of the intrinsic tryptophan and tyrosin fluorescence enables measurements at close-to-native conditions in any buffer, even in the presence of detergents. nanoDSF is applied in antibody engineering, membrane protein research, formulation and quality control.
More info >>

Industry Events

3D Cell Culture 2018

21-22 February 2018, Holiday Inn Kensington Forum, London UK

Building on the sell-out success of the launch event, SMi Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement